Tuesday 18 October 2016

Global Viral Infections Market to grow CAGR at 6.8% in 2021 - Promising New Competitors and Expanding Treatment Population to Offset Increased Uptake of Generics

ResearchMoz added Latest Research Report titled " Global Viral Infections Market to 2021 - Promising New Competitors and Expanding Treatment Population to Offset Increased Uptake of Generics " to it's Large Report database.

Viruses are infectious particles comprising a nucleic acid core – consisting of either DNA or RNA – and a protein coat known as a capsid. Infections attributable to viral pathogens are transmitted, directly or indirectly, from one person to another or from animal to human. Viruses replicate by exploiting the resources of their host cells, usually to the detriment of the host. As viral pathogens are exceptionally diverse, the morbidity associated with viral infections varies significantly depending on the virus in question. This report covers all viral infections, although particular focus is given to four key indications within this disease cluster: Human Immunodeficiency Virus (HIV), Hepatitis C Virus (HCV), Hepatitis B Virus (HBV) and influenza. The global viral infections market was valued at $74.0 billion in 2014, and is projected to grow at a considerable Compound Annual Growth Rate (CAGR) of 6.8%, reaching $117.6 billion in 2021. Key drivers of this growth will be the expanding treatment population and uptake of recently approved highly priced antiviral agents, as well as promising late-stage candidates that are expected to be priced highly.

Download free Sample PDF report with TOC: http://www.researchmoz.us/enquiry.php?type=S&repid=716911

Scope

The viral infections market is large and growing rapidly

    How do epidemiology trends differ among the key indications?
    What therapeutic options exist for preventing and treating viral infections?
    Which products and companies dominate the market?

The pipeline is innovative and diverse

    What is the proportion of early- to late-stage pipeline products?
    Which molecular targets are most prominent within the pipeline?
    How do the key indications differ in terms of molecule type?

Considerable market growth is anticipated throughout 2021

    Which products will contribute to this growth most significantly?
    Will the current market leaders retain their dominance over the forecast period?

Read All Pharmaceutical Market Research Reports @ http://www.researchmoz.us/pharmaceutical-market-reports-38.html

Table of Contents

1 Table of Contents 4
1.1 List of Tables 6
1.2 List of Figures 6

2 Introduction 9
2.1 Therapy Area Introduction 9
2.2 Human Immunodeficiency Virus (HIV) 9
2.2.1 Overview 9
2.2.2 Symptoms 10
2.2.3 Co-morbidities and Complications 10
2.2.4 Epidemiology 11
2.3 Hepatitis C Virus 12
2.3.1 Overview 12
2.3.2 Symptoms 13
2.3.3 Co-morbidities and Complications 13
2.3.4 Epidemiology 14
2.4 Hepatitis B Virus 14
2.4.1 Overview 14
2.4.2 Symptoms 15
2.4.3 Co-morbidities and Complications 15
2.4.4 Epidemiology 16

About ResearchMoz

ResearchMoz is the world's fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz's service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.

Contact Us:

Mr. Nachiket
Albany NY, United States - 12207
Tel: +1-518-621-2074 / Tel: 866-997-4948 (Us-Canada Toll Free)
Email: sales@researchmoz.us
Follow us on LinkedIn at: http://bit.ly/1TBmnVG

No comments:

Post a Comment